Mental wellbeing
Bipolar disorder: episodes, diagnosis, treatment goals, and monitoring
On this page
Bipolar disorder involves episodes of changed mood, energy and activity. High episodes can include irritability, restlessness or impulsive behaviour; depression can also occur. Episodes differ in severity, and some people have periods without symptoms.[1]
Episodes and diagnoses are related but different
| Term | Selected explanation |
|---|---|
| Mania | A marked episode of elevated or irritable mood with increased activity or energy; functioning can be seriously affected.[2] |
| Hypomania | A less severe elevated or irritable episode; it still belongs to a sustained pattern rather than any passing mood.[2] |
| Bipolar I | Includes a manic episode; depressive episodes may also occur.[2] |
| Bipolar II | Includes hypomanic and depressive episodes, without a full manic episode.[2] |
| Cyclothymic disorder | Recurring hypomanic and depressive symptoms that do not meet full episode thresholds.[2] |
The history matters more than a single symptom
Assessment asks about the duration, severity and sequence of episodes, sleep, functioning, medicines, substances and family history. Physical conditions such as thyroid problems can resemble mood symptoms. A questionnaire can support an assessment; it cannot establish the whole lifetime pattern.[2]
The NHS describes specialist assessment when bipolar disorder is suspected. Reduced need for sleep, racing thoughts, impulsive behaviour or psychotic symptoms can occur during high episodes. Severe deterioration or risk of self-harm requires timely clinical help, rather than waiting to complete an online mood tracker.[3]
Treatment includes both episodes and the intervals between them
Medicines may be used for high or low episodes and to reduce recurrence. Psychological therapy can help people understand patterns and manage difficulties. Sleep and daily routines can support a care plan, but they do not replace assessment or make all episodes preventable.[3]
NIMH cautions that antidepressant treatment alone can trigger mania or rapid cycling in some people with bipolar disorder. A depression treatment that is appropriate for one diagnosis should not automatically be transferred to another.[2]
A mood stabiliser can require laboratory monitoring
Lithium is a prescription mood stabiliser. Its concentration in blood needs monitoring because the useful range and the range associated with harm require careful management. Changes in salt intake can affect levels. Monitoring is part of treatment, rather than evidence that the medicine is always unsuitable.[4]
Possible lithium effects include nausea, tremor and tiredness; kidney or thyroid problems can develop with longer use. Confusion, coordination problems or significant new symptoms can indicate toxicity and need urgent assessment. The NHS describes routine checks and emergency actions separately. A general instruction to continue a medicine is not a reason to disregard suspected toxicity.[5]
Psychoeducation includes practising illness-management skills
Bipolar psychoeducation can combine information with guided practice: noticing early episode changes, monitoring symptoms and planning responses with the care team. It can use individual, group or family formats. Ask what skills the programme practises; receiving information alone is a different intervention.[8]
The trial below included cognitive behavioural therapy (CBT), working on thinking and behaviour; interpersonal and social rhythm therapy, addressing relationships and daily rhythms; and family-focused therapy, including communication skills. The names describe different treatment work.[9]
Evidence & uncertainty
Bipolar disorder is treatable, but response and side effects vary. Acute episode treatment and longer-term prevention have different goals. NHS guidance describes medicines, psychological therapy and regular routines as parts of care; feeling well does not automatically mean a maintenance medicine can be stopped.[3]
Selected-source overview · Independent review pendingPublished questions
Is bipolar disorder simply frequent mood swings?
Selected-source overview · Independent review pending. Read the evidence context.
No. It involves a pattern of episodes with changes in mood, energy and behaviour, rather than any rapid emotional change.[1]
Evidence behind this answer
- Bipolar disorder
agency patient explanation · Date not stated
Selected relevant official page passages inspected · Episodes, mood/energy changes and variable symptom-free intervals
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does mania always mean feeling happy?
Selected-source overview · Independent review pending. Read the evidence context.
No. A high episode can involve marked irritability as well as elevated mood, with changes in sleep, thinking or behaviour.[3]
Evidence behind this answer
- Bipolar disorder
agency patient explanation · 2024
Selected relevant official page passages inspected · Symptoms, specialist diagnosis, treatment, routines and urgent clinical concerns
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is bipolar II the same as bipolar I?
Selected-source overview · Independent review pending. Read the evidence context.
No. Bipolar I includes mania; bipolar II includes hypomania and depression without a full manic episode. These are diagnostic patterns, not labels assigned from one symptom.[2]
Evidence behind this answer
- Bipolar Disorder
agency patient explanation · Date not stated
Selected relevant official page passages inspected · Episode categories, lifetime assessment, physical mimics and antidepressant caution
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can the same antidepressant-only approach be assumed appropriate for bipolar depression?
Selected-source overview · Independent review pending. Read the evidence context.
No. NIMH warns that antidepressants alone can trigger mania or rapid cycling in some people with bipolar disorder. Treatment needs the diagnostic context.[2]
Evidence behind this answer
- Bipolar Disorder
agency patient explanation · Date not stated
Selected relevant official page passages inspected · Episode categories, lifetime assessment, physical mimics and antidepressant caution
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Why does lithium treatment involve blood tests?
Selected-source overview · Independent review pending. Read the evidence context.
Blood levels guide safe treatment because too much lithium can cause harm. Routine checks also help monitor relevant health effects.[4][5]
Evidence behind this answer
- About lithium
agency medicine explanation · 2023
Selected relevant official page passages inspected · Blood levels, monitoring and salt-related changes - Side effects of lithium
agency medicine explanation · 2023
Selected relevant official page passages inspected · Selected adverse effects, kidney/thyroid checks and toxicity warnings
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Do regular sleep and daily routines replace bipolar treatment?
Selected-source overview · Independent review pending. Read the evidence context.
No. They can support care alongside medicines and therapy, but do not replace assessment or a treatment plan.[3]
Evidence behind this answer
- Bipolar disorder
agency patient explanation · 2024
Selected relevant official page passages inspected · Symptoms, specialist diagnosis, treatment, routines and urgent clinical concerns
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are valproate risks during pregnancy and paternal exposure equally certain?
Selected-source overview · Independent review pending. Read the evidence context.
No. Pregnancy-related developmental risks are established; EMA’s June 2026 assessment found paternal-exposure evidence inconsistent and causality uncertain, while retaining precautions.[6][7]
Evidence behind this answer
- Valproate: reproductive risks
regulatory safety guidance · 2025
Selected relevant official page passages inspected · Pregnancy risks, reproductive discussions and avoiding abrupt unplanned changes - Meeting highlights from PRAC, 8–11 June 2026
regulatory safety assessment · 2026
Original agency indexed passages inspected; direct page retrieval returned 429 · Inconsistent paternal-exposure findings, uncertain causality and retained precautions
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
What would I practise in bipolar psychoeducation?
Selected-source overview · Independent review pending. Read the evidence context.
Programmes can teach recognition of early changes, symptom monitoring and planned responses. Ask whether sessions include guided practice, rather than information alone, and how those skills connect with your existing care plan.[8]
Evidence behind this answer
- Adjunctive Psychotherapy for Bipolar Disorder: A Systematic Review and Component Network Meta-analysis
systematic review and component network meta analysis · 2020
Original publisher abstract and relevant full-text component definitions, results and limitations read · 39 randomized trials; skill-practice components, recurrence, indirect comparisons and limitations
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Do I need a relative to attend bipolar therapy with me?
Selected-source overview · Independent review pending. Read the evidence context.
Not every approach requires family attendance. The trial included individual CBT and interpersonal and social rhythm therapy alongside a family-focused option. Ask about formats suited to your circumstances; the study did not establish one universal winner.[9]
Evidence behind this answer
- Psychosocial Treatments for Bipolar Depression: A 1-Year Randomized Trial From the Systematic Treatment Enhancement Program
original randomised trial · 2007
Original publisher abstract and relevant full-text methods, results and limitations read · 293 outpatients; brief versus intensive add-on care, family availability, contact imbalance and attrition
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
A longer therapy programme added benefit during bipolar depression
A 2007 trial assigned 293 depressed outpatients receiving medication care to brief psychoeducation or more intensive CBT, family-focused therapy, or interpersonal and social rhythm therapy. The intensive programmes improved recovery over one year. However, therapist contact differed and about one third left follow-up. The trial did not identify a best therapy among the three intensive approaches. The study tested added care during bipolar depression, not replacing medicines or treating acute mania.[9]
Separate established risks from an unresolved safety signal
UK MHRA guidance identifies established risks of birth defects and developmental problems with valproate exposure during pregnancy. It advises specialist discussions about pregnancy and reproductive risks. Treatment should not be changed abruptly without the appropriate clinical plan; the underlying condition also carries risks.[6]
EMA’s June 2026 review found inconsistent evidence about developmental risks in children whose fathers took valproate around conception. It judged a causal role uncertain and retained precautions while further research continues. That uncertainty concerns paternal exposure; it does not overturn established risks from exposure during pregnancy.[7]
The sources describe dated UK guidance and a subsequent EU safety assessment. Rules, eligibility and precautions are jurisdiction-specific. They should be read as such, rather than combined into one worldwide prescribing rule.[6][7]
Preventing another episode and treating current symptoms are different goals
A synthesis of 39 randomized trials found several structured therapies alongside medicines associated with fewer recurrences than usual care. Many comparisons were indirect, studies were small, and follow-up varied. Much symptom evidence concerned periods between episodes. This cannot rank the best programme for one person or establish that skills training prevents every episode. The synthesis includes the trial above, so they are not independent confirmations.[8]
References
- Bipolar disorder
Agency patient explanation
MedlinePlus Genetics / National Library of Medicine · Content/publication date: not stated
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Episodes, mood/energy changes and variable symptom-free intervalsSelected description; its simplified episode-duration wording was not adopted as diagnostic criteria.
- Bipolar Disorder
Agency patient explanation
NIMH · Content/publication date: not stated
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Episode categories, lifetime assessment, physical mimics and antidepressant cautionSelected explanatory passages. No diagnostic checklist or comparative treatment effect estimate was independently appraised.
- Bipolar disorder
Agency patient explanation
NHS · Content/publication date: 2024
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Symptoms, specialist diagnosis, treatment, routines and urgent clinical concernsPage reviewed 28 October 2024. Selected care passages; its separate causal-risk list was not adopted.
- About lithium
Agency medicine explanation
NHS · Content/publication date: 2023
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Blood levels, monitoring and salt-related changesReviewed 9 August 2023; listed next-review date has passed. Retrieval date is not a renewed medicine review. No dose or dietary adjustment is selected here.
- Side effects of lithium
Agency medicine explanation
NHS · Content/publication date: 2023
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Selected adverse effects, kidney/thyroid checks and toxicity warningsReviewed 9 August 2023. Emergency toxicity instructions and routine continuation advice are different situations.
- Valproate: reproductive risks
Regulatory safety guidance
MHRA · Content/publication date: 2025
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Pregnancy risks, reproductive discussions and avoiding abrupt unplanned changesUK guidance updated 23 September 2025. Not a worldwide prescribing rule. No individual probability or eligibility decision is inferred.
- Meeting highlights from PRAC, 8–11 June 2026
Regulatory safety assessment
European Medicines Agency · Content/publication date: 2026
Accessed: 2026-10-07 UTC · Original agency indexed passages inspected; direct page retrieval returned 429
Cited sections: Inconsistent paternal-exposure findings, uncertain causality and retained precautionsSelected committee summary, not independent appraisal of the underlying studies. English indexed text appears under the observed /no/ URL. Pregnancy exposure and paternal exposure are separate questions.
- Adjunctive Psychotherapy for Bipolar Disorder: A Systematic Review and Component Network Meta-analysis
Systematic review and component network meta analysis
Miklowitz, Efthimiou, Furukawa and colleagues · Content/publication date: 2020
Accessed: 2026-10-20 UTC · Original publisher abstract and relevant full-text component definitions, results and limitations read
Cited sections: 39 randomized trials; skill-practice components, recurrence, indirect comparisons and limitationsOnline October 2020; issue 2021. Search June 2019; overlapping trials and indirect comparisons limit treatment ranking.
- Psychosocial Treatments for Bipolar Depression: A 1-Year Randomized Trial From the Systematic Treatment Enhancement Program
Original randomised trial
Miklowitz, Otto, Frank and colleagues · Content/publication date: 2007
Accessed: 2026-10-20 UTC · Original publisher abstract and relevant full-text methods, results and limitations read
Cited sections: 293 outpatients; brief versus intensive add-on care, family availability, contact imbalance and attritionHistorical selected outpatient trial; contact time differed and intensive approaches were not proved equivalent. Included in the newer synthesis.
Scope & review
- Population
- General mental-health literacy, mainly adult care; children and pregnancy need separate assessment
- Exposure or intervention
- Mood episodes, specialist assessment, medicines, psychological care and safety monitoring
- Comparison
- Ordinary mood changes versus episodes; acute versus maintenance care; pregnancy versus paternal exposure
- Outcomes
- Symptoms, recurrence, functioning and medicine-related harms
- Timeframe
- Episode history and longer-term care; dated 2025 UK and June 2026 EU valproate information
- Jurisdiction
- US and UK education, with explicitly scoped UK and EU medicine-safety sources
Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-07 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
- 2026-10-20 UTC: Added bounded selected-source explanations and practical distinctions after full-body overlap audit; preserved previous content and citations. Qualified review remains pending.
What this article still leaves open
- Independent comparisons of medicines and therapies by episode, age and long-term outcome.
- Full appraisal and jurisdictional reconciliation of evolving valproate safety evidence.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.